A SQSTM1/p62 mutation linked to Paget’s disease increases the osteoclastogenic potential of the bone microenvironment
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Paget's disease of bone (PDB) is the second most common bone disease and is characterized by focal bone lesions which contain large numbers of abnormal osteoclasts (OCLs) and very active normal osteoblasts in a highly osteoclastogenic marrow microenvironment. The etiology of PDB is not well understood and both environmental and genetic causes have been implicated in its pathogenesis. Mutations in the SQSTM1/p62 gene have been identified in up to 30% of Paget's patients. To determine if p62 mutation is sufficient to induce PDB, we generated mice harboring a mutation causing a P-to-L (proline-to-leucine) substitution at residue 394 (the murine equivalent of human p62(P392L), the most common PDB-associated mutation). Bone marrow cultures from p62(P394L) mice formed increased numbers of OCLs in response to receptor activator of NF-kappaB ligand (RANKL), tumor necrosis factor alpha (TNF-alpha) or 1alpha,25-(OH)(2)D(3), similar to PDB patients. However, purified p62(P394L) OCL precursors depleted of stromal cells were no longer hyper-responsive to 1alpha,25-(OH)(2)D(3), suggesting effects of the p62(P394L) mutation on the marrow microenvironment in addition to direct effects on OCLs. Co-cultures of purified p62(P394L) stromal cells with either wild-type (WT) or p62(P394L) OCL precursors formed more OCLs than co-cultures containing WT stromal cells due to increased RANKL production by the mutant stromal cells. However, despite the enhanced osteoclastogenic potential of both OCL precursors and marrow stromal cells, the p62(P394L) mice had histologically normal bones. These results indicate that this PDB-associated p62 mutation is not sufficient to induce PDB and suggest that additional factors acting together with p62 mutation are necessary for the development of PDB in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Mutations in the gene coding for SQSTM1/p62 have been found in approximately 10% of PDB patients, and a mouse model carrying the P394L mutation exhibits a PDB‐like bone disorder with focal bone lesions, linked to enhanced autophagy activation in osteoclasts and detrimental bone remodeling (Hiruma et al, 2008).”
From Autophagy in major human diseases (2021) · cites this paper as Hiruma et al, 2008
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mutations in the gene coding for SQSTM1/p62 have been found in approximately 10% of PDB patients, and a mouse model carrying the P394L mutation exhibits a PDB‐like bone disorder with focal bone lesions, linked to enhanced autophagy activation in osteoclasts and detrimental bone remodeling (Hiruma et al, 2008).”
From Autophagy in major human diseases (2021) · cites this paper as Hiruma et al, 2008
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Increased osteoclastogenic potential of bone microenvironment, but histologically normal bones”
From Autophagy in major human diseases (2021) · cites this paper as Hiruma et al (2008)
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parfitt, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020617 · Cited by 5,016 · cited 1×
“All variables were expressed and calculated according to the recommendations of the American Society for Bone and Mineral Research Nomenclature Committee (37,38).”
MethodBone Histomorphometry : Standardization of Nomenclature, Symbols, and Units
PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · Cited by 3,258
Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone.
Laurin, N., Brown, J. P., Morissette, J., & Raymond, V. (2002) · The American Journal of Human Genetics · doi:10.1086/340731 · Cited by 563 · cited 1×
“However, mutations in only one of these genes, SQSTM1/p62, are generally associated with classical PDB (9,10), and up to 30% of familial PDB patients and 10% of sporadic patients have a p62 mutation (11–13).”
BackgroundDomain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget’s disease.
Hocking, L. J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.22.2735 · Cited by 350 · cited 1×
“However, mutations in only one of these genes, SQSTM1/p62, are generally associated with classical PDB (9,10), and up to 30% of familial PDB patients and 10% of sporadic patients have a p62 mutation (11–13).”
BackgroundRoodman, G. D., & Windle, J. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24281 · Cited by 340
Self-citationSignal integration and diversification through the p62 scaffold protein
MOSCAT, J., DIAZMECO, M., & WOOTEN, M. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.12.002 · Cited by 315 · cited 1×
“The p62 gene is ubiquitously expressed and encodes a 62 kDa protein that functions in multiple signal transduction pathways activated by receptor activator of NF-kB ligand (RANKL), tumor necrosis factor a (TNF-a) and IL-1, that promote osteoclast (OCL) formation at least in part through NF-kB activation (14).”
BackgroundPathophysiology and Treatment of Paget's Disease of Bone
Kanis, J. А. (1991) · Medical Entomology and Zoology · Cited by 308
Frequency and characteristics of familial aggregation of paget's disease of bone
Morales-Piga, A. A., Rey-Rey, J. S., Corres-González, J., Garc ÍA-Sagredo, J. M., & LÓPez-Abente, G. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100421 · Cited by 236
Familial aggregation of paget's disease of bone
Siris, E. S., Ottman, R., Flaster, E., & Kelsey, J. L. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650060511 · Cited by 218
Familial Aggregation of Paget's Disease of Bone
Siris, E. S., Ottman, R., Flaster, E., & Kelsey, J. L. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2005.20.3.541 · Cited by 187
Research works printed but not linked: 1
- Kurihara, N., Hiruma, Y., Zho, H., Subler, M.A., Dempster, D.W., Singer, F.R., Reddy, S.V., Gruber, H.E., Windle, J.J. and Roodman, G.D. (2007) Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease. J. Clin. Invest., 117, 133-142. · DOI · Paper page
Cited by
Selective autophagy mediated by autophagic adapter proteins
Johansen, T., & Lamark, T. (2011) · Autophagy · doi:10.4161/auto.7.3.14487 · Cited by 1,730
Autophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
p62 at the crossroads of autophagy, apoptosis, and cancer
Moscat, J., & Diaz-Meco, M. T. (2009) · Cell · doi:10.1016/j.cell.2009.05.023 · Cited by 1,073
Novack, D. V. (2011) · Cell Research · doi:10.1038/cr.2010.159 · Cited by 315
Molecular genetics of osteosarcoma
Rickel, K., Fang, F., & Tao, J. (2017) · Bone · doi:10.1016/j.bone.2016.10.017 · Cited by 244
Metadata
- Authors
- Hiruma, Y., Kurihara, N., Subler, M. A., Zhou, H., Boykin, C. S., Zhang, H., Ishizuka, S., Dempster, D. W., Roodman, G. D., & Windle, J. J.
- Affiliations
- University of Pittsburgh Medical Center (US)
- Helen Hayes Hospital (US)
- Virginia Commonwealth University (US)
- Teijin (Japan) (JP)
- VA Pittsburgh Healthcare System (US)
- Corresponding author
- Windle, Jolene J.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-09-02
- Volume
- 17
- Issue
- 23
- Pages
- 3708-3719
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- PMC
- PMC2581430
- OpenAlex
- W2151334165
- Cited by
- 90
- References
- 42
- Citations by year
- 2026: 1 · 2025: 3 · 2023: 4 · 2022: 4 · 2021: 7 · 2020: 5 · 2019: 3 · 2018: 5 · 2017: 3 · 2016: 4 · 2015: 3 · 2014: 7 · 2013: 7 · 2012: 6
- FWCI
- 3.84
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (RR024153, CA16059)
- VA Pittsburgh Healthcare System
- National Cancer Institute (P30CA16059, P30CA016059)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (P01AR049363, R01AR053537)
- Division of Materials Research
- National Center for Research Resources (RR-024153, UL1RR024153)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Keywords
- Paget's disease of bone, p62, osteoclastogenesis, bone marrow microenvironment, osteoclast precursors, stromal cells, RANKL, vitamin D, TNF-α, mouse model, pathogenesis
- MeSH terms
- Sequestosome-1 Protein, Animals, Bone Marrow, Bone Resorption, Cells, Cultured, Female, Humans, Male, Mice, Inbred C57BL, Mice, Transgenic, Osteitis Deformans, Osteoclasts, Stromal Cells, Mutation, Missense, Adaptor Proteins, Signal Transducing, Mice, RANK Ligand
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A SQSTM1/p62 mutation linked to Paget’s disease increases the osteoclastogenic potential of the bone microenvironment. https://app.cochat.ai/papers/10.1093/hmg/ddn266
- The paper
- Hiruma, Y., Kurihara, N., Subler, M. A., Zhou, H., Boykin, C. S., Zhang, H., Ishizuka, S., Dempster, D. W., Roodman, G. D., & Windle, J. J. (2008). A SQSTM1/p62 mutation linked to Paget’s disease increases the osteoclastogenic potential of the bone microenvironment. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddn266
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.